Influence of industry on renal guideline development

Affiliations

Review

Daniel W Coyne. Clin J Am Soc Nephrol. 2007 Jan.

. 2007 Jan;2(1):3-7; discussion 13-4.

doi: 10.2215/CJN.02170606. Epub 2006 Dec 6.

¹ Department of Medicine, Washington University, St. Louis, Missouri 63110, USA. dcoyne@im.wustl.edu

No abstract available

Comment in

Influence of industry on renal guideline development commentary: keeping our eye on the ball and improving chronic kidney disease patient outcomes.
Nissenson AR. Nissenson AR. Clin J Am Soc Nephrol. 2007 Mar;2(2):205-6. doi: 10.2215/CJN.03351006. Epub 2006 Dec 13. Clin J Am Soc Nephrol. 2007. PMID: 17699409 No abstract available.
Comments on the guideline debate.
Amerling R, Winchester JF. Amerling R, et al. Clin J Am Soc Nephrol. 2007 Mar;2(2):208. doi: 10.2215/CJN.00200107. Clin J Am Soc Nephrol. 2007. PMID: 17699411 No abstract available.
Commentary on "Influence of industry on renal guideline development".
Campbell D, Walker R, Mathew T, Craig J. Campbell D, et al. Clin J Am Soc Nephrol. 2007 Mar;2(2):211. doi: 10.2215/CJN.00300107. Clin J Am Soc Nephrol. 2007. PMID: 17699413 No abstract available.
Stacking the deck.
Kassirer JP. Kassirer JP. Clin J Am Soc Nephrol. 2007 Mar;2(2):212. doi: 10.2215/CJN.0660207. Clin J Am Soc Nephrol. 2007. PMID: 17699414 No abstract available.
Anemia of kidney disease and clinical practice guidelines: quo vadis?
Himmelfarb J, Henrich W, DuBose T. Himmelfarb J, et al. Clin J Am Soc Nephrol. 2007 Mar;2(2):213-4. doi: 10.2215/CJN.04401206. Clin J Am Soc Nephrol. 2007. PMID: 17699415 No abstract available.